Skip to main content
. 2020 Jul 15;11(1):1–12. doi: 10.1016/j.jcmgh.2020.07.005

Table 2.

Inflammation Markers in UST-Treated CD Patients

UST <4 mg/L (n = 14) UST >4 mg/L (n = 7) P Value
HBI 6.5 ± 7.7 7 ± 12.7 .3
C-reactive protein, mg/L 17 ± 17 34 ± 60 .65
Leukocytes, ×103/μL 8.9 ± 2.7 8.7 ± 1.9 >.9

Values are mean ± SD.

CD, Crohn’s disease; HBI, Harvey-Bradshaw Index; UST, ustekinumab.